Asth­ma pa­tients are un­fa­mil­iar with bi­o­log­ic brands, but open to try — Phree­sia sur­vey

Peo­ple liv­ing with asth­ma are open to try­ing new bi­o­log­ic treat­ments now on the mar­ket — they just haven’t heard of them. On­ly 5% have heard …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA